Myovant, Sumitomo Call Alleged Skadden Conflict Public Info
By Katryna Perera · November 2, 2023, 4:49 PM EDT
Executives of Sumitomo Pharma America Inc. and Myovant Sciences Ltd. have urged a New York federal judge to toss a proposed class action claiming the companies' merger was undervalued because lawyers...
To view the full article, register now.